CAN-FITE BIOPHARMA LTD's ticker is CANF and the CUSIP is 13471N102. A total of 12 filers reported holding CAN-FITE BIOPHARMA LTD in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $23,000 | – | 10,421 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EQUITEC SPECIALISTS, LLC | 118,850 | $265,000 | 0.08% |
| TAYLOR ASSET MANAGEMENT INC | 18,900 | $42,000 | 0.01% |
| MENTA CAPITAL LLC | 12,200 | $27,000 | 0.00% |
| Virtu KCG Holdings LLC | 50,415 | $112,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 696 | $2,000 | 0.00% |
| DEUTSCHE BANK AG\ | 7,476 | $16,000 | 0.00% |
| Renaissance Technologies | 85,000 | $190,000 | 0.00% |
| UBS Group AG | 2,261 | $5,000 | 0.00% |
| CITIGROUP INC | 487 | $1,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 10,421 | $23,000 | 0.00% |